Evidence map›Paper›PMID 28715724›Full record

ArticleJournal of affective disorders2017

Toxoplasma gondii infection and common mental disorders in the Finnish general population.

Jaana Suvisaari, Minna Torniainen-Holm, Maija Lindgren, Tommi Härkänen, Robert H Yolken

Open access · greenAbstract read
In one paragraph

Article in Journal of affective disorders, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. Systematic review and modelling ofEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. From cats to cortex:Frontiers in psychiatry · 2026
    Review
  7. Article
  8. Article
  9. Review
  10. Anti-Pathogens (Basel, Switzerland) · 2023
    Review
  11. Review
  12. Global seroprevalence ofHealth science reports · 2023
    Article
  13. Iranian journal of public health · 2023
    Article
  14. From the immune system to mood disorders especially induced byFrontiers in cellular and infection microbiology · 2023
    Review
  15. Article
  16. Article
  17. Medicina (Kaunas, Lithuania) · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Jaana SuvisaariNational Institute for Health and Welfare (THL), Department of Public Health Solutions, P.O. Box 30, FI-00271 Helsinki, Finland. Electronic address: jaana.suvisaari@thl.fi.
Minna Torniainen-HolmNational Institute for Health and Welfare (THL), Department of Public Health Solutions, P.O. Box 30, FI-00271 Helsinki, Finland; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, P.O. Box 20, FI-00014, Finland. Electronic address: minna.torniainen-holm@thl.fi.
Maija LindgrenNational Institute for Health and Welfare (THL), Department of Public Health Solutions, P.O. Box 30, FI-00271 Helsinki, Finland. Electronic address: maija.lindgren@thl.fi.
Tommi HärkänenNational Institute for Health and Welfare (THL), Department of Public Health Solutions, P.O. Box 30, FI-00271 Helsinki, Finland. Electronic address: tommi.harkanen@thl.fi.
Robert H YolkenStanley Division of Developmental Neurovirology, Stanley Neurovirology Laboratory, Johns Hopkins University, School of Medicine, 600 North Wolfe Street, Blalock 1105, Baltimore, MD 21287, USA. Electronic address: rhyolken@gmail.com.
Finnish Institute for Health and Welfare · FIJohns Hopkins University · US

Funding

Project 3P50MH094268 · NIMH · JOHNS HOPKINS UNIVERSITY · PI SAWA, AKIRA · 2011 to 2020
$19.9M
NIMH NIH HHS P50 MH094268
6 · The paper itself

Abstract

objectiveWe investigated whether T. gondii seropositivity is associated with 12-month depressive, anxiety and alcohol use disorders and current depressive symptoms and whether inflammation, measured by C-reactive protein (CRP) level, explains these associations.

methodHealth 2000 study (BRIF8901), conducted in years 2000-2001, is based on a nationally representative sample of Finns aged 30 and above, with 7112 participants and 88.6% response rate. DSM-IV depressive, anxiety and alcohol use disorders were assessed with the Composite International Diagnostic Interview and depressive symptoms with the Beck Depressive Inventory (BDI-21). We used logistic regression to investigate the association of T. gondii seropositivity with mental disorders and linear regression with BDI-21 scores.

resultsT. gondii seroprevalence was significantly associated with 12-month generalized anxiety disorder but not with other anxiety, depressive or alcohol use disorders. T. gondii seropositivity was associated with higher BDI-21 scores (beta 0.56, 95% CI 0.12-1.00, P = 0.013) and with having a comorbid depressive and anxiety disorder (OR 1.86, 95% CI 1.16-2.97, P = 0.010). Higher CRP levels were associated with these outcomes and with T. gondii seropositivity, but adjusting for CRP did not change the effect of T. gondii seropositivity. LIMITATIONS: Cross-sectional study design with no information on the timing of T. gondii infection.

conclusionT. gondii seropositivity is associated with generalized anxiety disorder, depressive symptoms and comorbid depressive and anxiety disorders, which is not mediated by inflammation.

Indexed as

AdultAgedAlcoholismAnxiety DisordersC-Reactive ProteinCross-Sectional StudiesDepressionDiagnostic and Statistical Manual of Mental DisordersFemaleFinlandHealth SurveysHumansMaleMental DisordersMiddle AgedSeroepidemiologic StudiesC-Reactive ProteinAlcohol use disordersAnxiety disordersC-reactive proteinDepressive disordersGeneralized anxiety disorderToxoplasma gondii

Identifiers

PMID28715724
PMCPMC5588865
OpenAlexW2734977768

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.